Aktionsplan Shanghai Pharmaceuticals Holding Co., Ltd
Erweiterter Zeitplan
Einfaches Diagramm
Über das Unternehmen
Shanghai Pharmaceuticals Holding Co., Ltd. researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in China and internationally. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including anti-tumor, heart and cerebral vessels, psychoneural, anti-infection, auto-immunity, digestive tract and metabolism, and respiratory system. It provides approximately 700 varieties of drugs. weitere detailsEBITDA | 75.53 |
---|---|
EV/EBITDA | 2.04 |
Industry | Health Care Providers & Services |
P/BV | 0.1122 |
P/E | 1.36 |
P/S | 0.0297 |
Sector | Health Care |
Валюта | usd |
Валюта отчета | usd |
Выручка | 1303.29 |
Див.доход ао | 5.78 |
Дивиденд ао | 0.4089 |
Сайт | https://www.sphchina.com |
Цена ао | 1.49 |
Число акций ао | 3.70129 млрд |
Preisänderung pro Tag: | 0% (1.64) |
---|---|
Preisänderung pro Woche: | -2.67% (1.685) |
Preisänderung pro Monat: | -9.89% (1.82) |
Preisänderung über 3 Monate: | +0.6135% (1.63) |
Preisänderung über sechs Monate: | +13.73% (1.442) |
Preisänderung pro Jahr: | +5.81% (1.55) |
Preisänderung über 3 Jahre: | +4.46% (1.57) |
Preisänderung über 5 Jahre: | 0% (1.64) |
Preisänderung über 10 Jahre: | 0% (1.64) |
Preisänderung seit Jahresbeginn: | +29.13% (1.27) |
|
Unterschätzung
|
Effizienz
|
|||||||||||||||||||||||||||||||||||||
Dividenden
|
Pflicht
|
Wachstumsimpuls
|
Dividende, % | Dividende | Basierend auf den Ergebnissen des Zeitraums | Vorher kaufen | Anmeldeschlussdatum | Auszahlung vorher |
---|---|---|---|---|---|
0.67% | 0.01 | II кв. 2024 | 13.09.2024 | 17.09.2024 | 02.10.2024 |
5.39% | 0.08 | II кв. 2023 | 14.07.2023 | 18.07.2023 | 02.08.2023 |
Institutionen | Volumen | Aktie, % |
---|---|---|
Vanguard International Stock Index-Emerging Markets Stk | 12146926 | 1.32 |
Vanguard International Stock Index-Total Intl Stock Indx | 11883576 | 1.29 |
iShares Core MSCI Emerging Markets ETF | 7102300 | 0.77 |
Brandes Emerging Markets Value Fund | 5203000 | 0.57 |
DFA Emerging Markets Core Equity Portfolio | 4172100 | 0.45 |
iShares MSCI Emerging Markets Minimum Volatility Factor ETF | 3566400 | 0.39 |
DFA Investment Dimensions-DFA Emerging Mkts Value | 3299900 | 0.36 |
iShares ESG Aware MSCI EM ETF | 3014100 | 0.33 |
iShares MSCI China ETF | 2093800 | 0.23 |
iShares MSCI Emerging Markets ETF | 1923800 | 0.21 |
Aufsicht | Berufsbezeichnung | Zahlung | Geburtsjahr |
---|---|---|---|
Mr. Bo Shen | President, CFO, Head of the Accounting Department & Executive Director | 804.26k | 1973 (52 Jahr) |
Mr. Yongzhong Li | VP & Executive Director | 904.39k | 1970 (55 Jahre) |
Mr. Tao Zhong | VP, Board Secretary & Joint Company Secretary | N/A | 1972 (53 Jahr) |
Mr. Dongming Li | Vice President | N/A | 1969 (56 Jahre) |
Ms. Shuai Shao | Vice President | N/A | 1988 (37 Jahre) |
Dr. Shunjiang Yu | Chief Medical Officer | N/A | |
Mr. Ming Dong | Executive Director | N/A | 1976 (49 Jahre) |
Ying Ke | Director & General Manager of R&D Management Center | N/A | |
Mr. Qiuhua Yang | Executive Chairman | N/A | 1972 (53 Jahr) |
Ms. Pui Kiu Wong | Joint Company Secretary | N/A |
Adresse: China, Shanghai, Shanghai Pharmaceutical Building - in Google Maps öffnen, Öffnen Sie Yandex-Karten
Webseite: https://www.sphchina.com
Webseite: https://www.sphchina.com